Document pB7yDrjwEDzZY46o9OKEdkD9k

To: Cc: From: Sent: Subject: Received: @rivm.nl] @chemours.com]; restrictiePFAS [IIE Mon 11/16/2020 11:45:29 AM RE: ?RE: Extension request - Chemours response to RPA questionnaire Mon 11/16/2020 11:46:44 AM @ ivm nl] 2965898 Thank you for your prompt reply. We will reach out to RPA to discuss the extension. Best regards 5.1.2e Fluoropolymers n oe Office 951-6 Company 1007 Market Street Wilmington, DE 19801 < Chemours LinkedIn | Twitter | Chemours.com prom: IEE INEKEC cr. > Sent: Monday, November 16, 2020 2:52 AM To: 5.1.2e < 5.1.2e @chemours.com> JE Cc: 5.1.2e < 5.1.2e @chemours.com>; restrictiePFAS Subject: ?RE: Extension request - Chemours response to RPA questionnaire @rivm.ni> [External email. Confirm links and attachments before opening. Dear [EAE We highly appreciate the contribution from Chemours in the call for evidence and the follow up questionnaires. Last week, we had a meeting with our colleagues from the other countries and we agreed to give the respective consultants additional time to finalize their reports. This will allow the consultants to extend the deadlines they are using for their contacts with stakeholders. It is now up to RPA to decide which deadline they will use for Chemours (I can imagine that they will keep the general deadline the same to avoid too many late reactions, but use another deadline for big organizations with complex supply chains. So | leave this decision at RPA). Kind regards, 5.1.2e rivm.nl RIVM, Centre for Safety of Substances and Products Antonie van Leeuwenhoeklaan 9 | 3721 MA Bilthoven | The Netherlands P.O. Box 1 | 3720 BA Bilthoven | www.rivm.nl/en WWW. fE rre pr rogr Sent: 13 nl 2020 14:37 @ rivm.nl> @chemours.com> Subject: Extension request - Chemours response to RPA questionnaire [IEEE I hope this email finds you well. My colleague, - nd | submitted response to the "Call for Evidence supporting an analysis of restriction options for PFAS" earlier this year on behalf of The Chemours Company. We have now received an invitation from RPA (working on behalf of RIVM) to provide additional information for their study on the "manufacture/ production of PFAS substances relevant for use in the European Economic Area". While we welcome the opportunity to continue to work closely with you and all Member States, we do have concerns about the extremely short deadlines we are given to complete this questionnaire. We consider this to be of the utmost importance for our company and industry and we want to provide high quality input. However, given the breadth of the questionnaire, the complexity of our supply chain and the current pandemic situation, we do not feel that we have adequate time to provide the detailed information requested by November 30%". We are kindly requesting an extension of the response deadline to the end of February 2021. 2965898 Again, we welcome this opportunity and want to provide you the most complete set of data so that the information can be utilized in the CA's work to draft proposals relying on balanced stakeholder input. We feel this additional time now would possibly circumvent complex data submissions at a later time. I will reach out to you early next week so that we can speak about this extension request and | can answer any questions you may have. Please do feel free to reach out to me directly at any time if you have questions. Best regards Fluoropolymers The Chemours Company Office 951-6 1007 Market Street Wilmington, DE 19801 { Chemours- LinkedIn | Twitter | Chemours.com This communication is for use by the intended recipient and contains information that may be privileged, confidential or copyrighted under applicable law. If you are not the intended recipient, you are hereby formally notified that any use, copying or distribution of this e-mail, in whole or in part, is strictly prohibited. Please notify the sender by return e-mail and delete this e-mail from your system. Unless explicitly and conspicuously designated as "E-Contract Intended", this e-mail does not constitute a contract offer, a contract amendment, or an acceptance of a contract offer. This e-mail does not constitute a consent to the use of sender's contact information for direct marketing purposes or for transfers of data to third parties. https:/www.chemours.com/en/email-disclaimer Dit bericht kan informatie bevatten die niet voor u is bestemd. Indien u niet de geadresseerde bent ofdit bericht abusievelijk aan u is verzonden, wordt u verzocht dat aan de afzender te melden en het bericht te verwijderen. Het RIVM aanvaardt geen aansprakelijkheid voor schade, van welke aard ook, die verband houdt met risico's verbonden aan het elektronisch verzenden van berichten. www. rivin.nl De Zorg voor morgen begint vandaag for you. This message may contain information that is not intended Ifyou are not the addressee or if this message was sent to you by mistake, you are requested to inform the sender and delete no the message. RIVM accepts liability for damage of any kind resulting from the risks inherent in the electronic transmission ofmessages. www.rivin.nVen Committed to health and sustainability This communication is for use by the intended recipient and contains information that may be privileged, confidential or copyrighted under applicable law. If you are not the intended recipient, you are hereby formally notified that any use, copying or distribution of this e-mail, in whole or in part, is strictly prohibited. Please notify the sender by return e-mail and delete this e-mail from your system. Unless explicitly and conspicuously designated as "E-Contract Intended", this email does not constitute a contract offer, a contract amendment, or an acceptance of a contract offer. This e-mail does not constitute a consent to the use of sender's contact information for direct marketing purposes or for transfers of data to third parties. https://www_.chemours.com/en/email-disclaimer